Use of blood and blood products in trauma

Best Practice and Research: Clinical Anaesthesiology

Volumn 21, Issue 2, 2007, Pages 257-270

  Grottke, Oliver ^b   Henzler, Dietrich ^b   Rossaint, Rolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

blood products; coagulopathy; haemorrhage; haemostasis; trauma

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD CLOTTING FACTOR; DESMOPRESSIN; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; FRESH FROZEN PLASMA; HEPARIN; OXYGEN; PLACEBO; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; VITAMIN K GROUP; WARFARIN;

ACIDOSIS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLUNT TRAUMA; CLINICAL TRIAL; CONTINUOUS INFUSION; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG OVERDOSE; EMERGENCY PATIENT; ERYTHROCYTE TRANSFUSION; FIBRINOGEN DEFECT; FIBRINOLYSIS; GLANZMANN DISEASE; HEMODILUTION; HEMOPHILIA; HEMORRHAGIC SHOCK; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOTHERMIA; INTERNATIONAL NORMALIZED RATIO; LOADING DRUG DOSE; PARTIAL THROMBOPLASTIN TIME; PENETRATING TRAUMA; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOEMBOLISM; TISSUE OXYGENATION; TRANSFUSION RELATED ACUTE LUNG INJURY; VON WILLEBRAND DISEASE;

ALGORITHMS; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; CLINICAL PROTOCOLS; ERYTHROCYTE TRANSFUSION; GUIDELINES; HEMORRHAGE; HEMOSTASIS; HUMANS; PLASMA SUBSTITUTES; PRACTICE GUIDELINES; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 34250016211     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.02.001     Document Type: Review

References (98)

1. Gofrit O.N., Leibovici D., Shapira S.C., et al. The trimodal death distribution of trauma victims: military experience from the Lebanon War. Military Medicine 162 (1997) 24-26
2. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. The Journal of Trauma 38 (1995) 185-193
3. MacLeod J.B., Lynn M., McKenney M.G., et al. Early coagulopathy predicts mortality in trauma. The Journal of Trauma 55 (2003) 39-44
4. Brohi K., Singh J., Heron M., and Coats T. Acute traumatic coagulopathy. The Journal of Trauma 54 (2003) 1127-1230
5. Ferrara A., MacArthur J.D., Wright H.K., et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. American Journal of Surgery 160 (1990) 515-518
6. Krishna G., Sleigh J.W., and Rahman H. Physiological predictors of death in exsanguinating trauma patients undergoing conventional trauma surgery. The Australian and New Zealand Journal of Surgery 68 (1998) 826-829
7. Yoshihara H., Yamamoto T., and Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thrombosis Research 37 (1985) 503-512
8. Douning L.K., Ramsay M.A., Swygert T.H., et al. Temperature corrected thrombelastography in hypothermic patients. Anesthesia and Analgesia 81 (1995) 608-611
9. Meng Z.H., Wolberg A.S., Monroe III D.M., and Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. The Journal of Trauma 55 (2003) 886-891
10. Rossaint R., Cerny V., Coats T.J., et al. Key issues in advanced bleeding care in trauma. Shock 26 (2006) 322-331
11. American College of Surgeons. Advanced Trauma Life Support (ATLS) for Doctors. 7th edn. (2004), American College of Surgeons, Chicago, IL
12. Abramson D., Scalea T.M., Hitchcock R., et al. Lactate clearance and survival following injury. The Journal of Trauma 35 (1993) 584-588
13. Davis J.W., Parks S.N., Kaups K.L., et al. Admission base deficit predicts transfusion requirements and risk of complications. The Journal of Trauma 41 (1996) 769-774
14. Erber W.N. Massive blood transfusion in the elective surgical setting. Transfusion and Apheresis Science 27 (2002) 83-92
15. Harvey M.P., Greenfield T.P., Sugrue M.E., and Rosenfeld D. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications. The Medical journal of Australia 163 (1995) 356-359
16. Spahn D., and Rossaint R. Coagulopathy and blood component transfusion in trauma. British Journal of Anaesthesia 95 (2005) 130-139
17. Simmons R.L., Collins J.A., Heisterkamp C.A., et al. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Annals of Surgery 169 (1969) 455-482
18. Faringer P.D., Mullins R.J., Johnson R.L., and Trunkey D.D. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. The Journal of Trauma 34 (1993) 481-485
19. Repine T.B., Perkins J.G., Kauvar D.S., and Blackborne L. The use of fresh whole blood in massive transfusion. Trauma 60 (2006) 59-69
20. Mabry R.L., Holcomb J.B., Baker A.M., et al. United States Army Rangers in Somalia: an analysis of combat casualties on an urban battlefield. The Journal of Trauma 49 (2000) 515-528
21. Eberst M.E., and Berkowitz L.R. Hemostasis in renal disease: pathophysiology and management. The American Journal of Medicine 96 (1994) 168-179
22. Valeri C.R., Cassidy G., Pivacek L.E., et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41 (2001) 977-983
23. Bombeli T., and Spahn D.R. Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. British Journal of Anaesthesia 93 (2004) 275-287
24. Peyrou V., Lormeau J.C., Herault J.P., et al. Contribution of erythrocytes to thrombin generation in whole blood. Thrombosis and Haemostasis 81 (1999) 400-406
25. Moore F.A., Moore E.E., and Sauaia A. An independent risk factor for postinjury multiple organ failure. Archives of Surgery 132 (1997) 620-624
26. Sauaia A., Moore F.A., Moore E.E., et al. Multiple organ failure can be predicted as early as 12 hours after injury. The Journal of Trauma 45 (1998) 291-303
27. Claridge J.A., Sawyer R.G., Schulman A.M., et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. The American Surgeon 68 (2002) 566-572
28. Edna T.H., and Bjerkeset T. Association between blood transfusion and infection in injured patients. The Journal of Trauma 33 (1992) 659-661
29. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine 340 (1999) 409-417
30. McIntyre L., Hebert P.C., Wells G., et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?. The Journal of Trauma 57 (2004) 563-568
31. Malone D.L., Dunne J., Tracy J.K., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. The Journal of Trauma 54 (2003) 898-907
32. Croce M.A., Tolley E.A., Claridge J.A., and Fabian T.C. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. The Journal of Trauma 59 (2005) 19-23
33. Hiippala S. Replacement of massive blood. Vox Sanguinis 74 (1998) 399-407
34. American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guidelines for blood component therapy. Anesthesiology 84 (1996) 732-747
35. College of American Pathologists. Practice parameters for the use of fresh frozen plasma, cryoprecipitate and platelets. JAMA: The Journal of the American Medical Association 271 (1994) 777-781
36. Ness P., Braine H., King K., et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 41 (2001) 857-861
37. Murray D.J., Pennell B.J., Weinstein S.L., and Olson J.D. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding. Anesthesia and Analgesia 80 (1995) 336-342
38. Slichter S.J. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfusion Medicine Reviews 18 (2004) 153-167
39. British Committee for Standards in Haematology Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. British Journal of Haematology 122 (2003) 10-23
40. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1 (1996) 3-40
41. Chen L., Bracey A.W., Radovancevic R., et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 128 (2004) 425-431
42. Hardy J.F., de Moerloose P., Samama C.M., and Members of the Groupe d'Interet en Hemostase Perioperatoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Canadian Journal of Anaesthesia 53 (2006) 40-58
43. Kleinman S., Chan P., and Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfusion Medicine Reviews 17 (2003) 120-162
44. Martin D.J., Lucas C.E., Ledgerwood A.M., et al. Fresh frozen plasma supplement to massive red blood cell transfusion. Annals of Surgery 202 (1985) 505-511
45. Popovsky M.A. Transfusion-related acute lung injury. In: Popovsky M.A. (Ed). Transfusion Reactions (2001), AABBPress, Bethesda
46. Phillips T.F., Soulier G., and Wilson R.F. Outcome of massive transfusion exceeding two blood volumes in trauma and emergency surgery. The Journal of Trauma 27 (1987) 903-910
47. Wallace E.L. Monitoring the nation's blood supply. Transfusion 43 (2003) 299-301
48. Stanworth S.J., Brunskill S.J., Hyde C.J., et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. British Journal of Haematology 126 (2004) 139-152
49. Makris M., Greaves M., Phillips W.S., et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis 77 (1997) 477-480
50. Nitu I.C., Perry D.J., and Lee C.A. Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal. Clinical and Laboratory Haematology 20 (1998) 363-367
51. O'Shaughnessy D.F., Atterbury C., Bolton Maggs P., et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology 126 (2004) 11-28
52. Menzebach A., Cassens U., Van Aken H., and Booke M. Strategies to reduce perioperative blood loss related to non-surgical bleeding. European Journal of Anaesthesiology 20 (2003) 764-770
53. Makris M., and Watson H.G. The management of coumarin-induced over-anticoagulation. British Journal of Haematology 114 (2001) 271-280
54. Cote C.J., Drop L.J., Hoaglin D.C., et al. Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children: effects of infusion rate, duration, and treatment with calcium chloride. Anesthesia and Analgesia 67 (1988) 152-160
55. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Seminars in Thrombosis and Hemostasis 32 (2006) 77-85
56. He S., Blomback M., Jacobsson Ekman G., and Hedner U. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. Journal of Thrombosis and Haemostasis 1 (2003) 1215-1219
57. Martinowitz U., Holcomb J.B., Pusateri A.E., et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. The Journal of Trauma 50 (2001) 721-729
58. Kenet G., Walden R., Eldad A., and Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354 (1999) 1879
59. O'Connell K.A., Wood J.J., Wise R.P., et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA: The Journal of the American Medical Association 18 (2006) 293-298
60. Dutton R.P., Cooper C., Jones A., et al. Daily multidisciplinary rounds shorten length of stay for trauma patients. The Journal of Trauma 55 (2003) 913-919
61. Martinowitz U., and Michaelson M. The Israeli Multidisciplinary rFVIIa Task Force Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. Journal of Thrombosis and Haemostasis 3 (2005) 640-648
62. Boffard K.D., Riou B., Warren B., et al. NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. The Journal of Trauma 5 (2005) 8-15
63. Vincent J.L., Rossaint R., Riou B., et al. Recommandations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective. Critical Care 10 (2006) R120
64. Hiippala S.T., Myllyla G.J., and Vahtera E.M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 81 (1995) 360-365
65. Innerhofer P., Fries D., Klingler A., and Streif W. In vivo effect of haemodilution with saline on coagulation. British Journal of Anaesthesia 89 (2002) 934-939
66. Fries D., Innerhofer P., Reif C., et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesthesia and Analgesia 102 (2006) 347-351
67. Fries D., Krismer A., Klingler A., et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Journal of Anaesthesia 95 (2005) 172-177
68. Hanley J.P. Warfarin reversal. Journal of Clinical Pathology 57 (2004) 1132-1139
69. Preston F.E., Laidlaw S.T., Sampson B., and Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. British Journal of Haematology 116 (2002) 619-624
70. Evans G., Luddington R., and Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. British Journal of Haematology 115 (2001) 998-1001
71. Erber W.N., and Perry D.J. Plasma and plasma products in the treatment of massive haemorrhage. Best Practice & Research. Clinical Haematology 19 (2006) 97-112
72. Kohler M. Thrombogenicity of prothrombin complex concentrates. Thrombosis Research 95 (1999) 13-17
73. Lusher J.M. Thrombogenicity associated with factor IX complex concentrates. Seminars in Hematology 28 (1991) 3-5
74. Enderson B.L., Chen J.P., Robinson R., and Maull K.I. Fibrinolysis in multisystem trauma patients. The Journal of Trauma 31 (1991) 1240-1246
75. Engelman D.T., Gabram S.G., Allen L., et al. Hypercoagulability following multiple trauma. World Journal of Surgery 20 (1996) 5-10
76. Risberg B., Medegard A., Heideman M., et al. Early activation of humoral proteolytic systems in patients with multiple trauma. Critical Care Medicine 14 (1986) 917-925
77. Casati V., Sandrelli L., Speziali G., et al. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: a prospective, randomized, double-blind, placebo-controlled study. The Journal of Thoracic and Cardiovascular Surgery 123 (2002) 1084-1091
78. Mossinger H., Dietrich W., Braun S.L., et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. The Annals of Thoracic Surgery 75 (2003) 430-437
79. Mahdy A.M., and Webster N.R. Perioperative systemic haemostatic agents. British Journal of Anaesthesia 93 (2004) 842-858
80. Franck M., and Sladen R.N. Drugs to prevent and reverse anticoagulation. Anesthesiology Clinics of North America 17 (1999) 799-811
81. Hoffmann H., Siebeck M., Thetter O., et al. Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo. Advances in Experimental Medicine and Biology 247 (1989) 35-42
82. Royston D., Bidstrup B.P., Taylor K.M., and Sapsford R.N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2 (1987) 1289-1291
83. Porte R.J., and Leebeek F.W. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62 (2002) 2193-2211
84. Dietrich W., Spath P., Ebell A., and Richter J.A. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart opera-tions. The Journal of Thoracic and Cardiovascular Surgery 113 (1997) 194-201
85. Mangano D.T., Tudor I.C., Dietzel C., Multicenter Study of Perioperative Ischemia Research Group, and Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. The New England Journal of Medicine 354 (2006) 353-365
86. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
87. http://www.fda.gov/cder/drug/infosheets/hcp/aprotininhcp.htm [accessed October 2006].
88. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 29 (1985) 236-261
89. Henry D.A., Moxey A.J., Carless P.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 1 (2001) CD001886
90. Coats T., Roberts I., and Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database of Systematic Reviews (2004) CD004896
91. www.crash2.LSHTM.ac.uk [accessed October 2006].
92. Levi M., Cromheecke M.E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354 (1999) 1940-1947
93. Mannucci P.M. Treatment of von Willebrand's Disease. The New England Journal of Medicine 351 (2004) 683-694
94. Mannucci P.M. Hemostatic drugs. The New England Journal of Medicine 23 339 (1998) 245-253
95. Gratz I., Koehler J., Olsen D., et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. The Journal of Thoracic and Cardiovascular Surgery 104 (1992) 1417-1422
96. Sheridan D.P., Card R.T., Pinilla J.C., et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Canadian Journal of Surgery 37 (1994) 33-36
97. Pleym H., Stenseth R., Wahba A., et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia 98 (2004) 578-584
98. Carless P.A., Henry D.A., Moxey A.J., et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 1 (2004) CD001884